首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1524243

生化試劑市場 - 按產品類型（PCR、細胞和組織培養、電泳和色譜試劑）、應用（基因組學、蛋白質組學、診斷、藥物發現和開發）、最終用途 - 全球預測（2024 - 2032）

Biochemical Reagents Market - By Product Type (PCR, Cell & Tissue Culture, Electrophoresis, & Chromatography Reagents), Application (Genomics, Proteomics, Diagnostics, Drug Discovery & Development), End-use - Global Forecast (2024 - 2032)

出版日期: 2024年04月24日 | 出版商:

Global Market Insights Inc. | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在個人化醫療日益轉變的推動下，全球生化試劑市場預計從 2024 年到 2032 年複合年成長率將超過 8.5%。隨著醫療保健轉向基於個人基因圖譜的客製化治療，對用於基因測試和分子診斷的生化試劑的需求不斷增加。這些試劑在識別影響疾病易感性和治療反應的遺傳變異和生物標記方面發揮著至關重要的作用。

在此背景下，2024 年 7 月，威斯康辛州生物健康技術中心獲得了 4,900 萬美元的聯邦資金，用於推動精準醫療。該投資旨在促進個人化醫療領域的創新、生產能力和勞動力發展。

這一趨勢反映了對精準醫療保健的更廣泛重視，其中準確和特定的生化檢測對於開發標靶療法和改善患者治療結果以及繁榮研究、診斷和治療應用市場向前發展至關重要。

整個生化試劑市場根據產品類型、應用、最終用途和地區進行分類。

基因組學領域將在 2024 年至 2032 年期間呈現出顯著的複合年成長率。由於基因組研究和個人化醫療的進步，基因組學領域將經歷高潮。這些試劑對於基因組學中的 DNA 定序、PCR 擴增和基因表現分析等任務至關重要。隨著在理解遺傳變異、疾病機制和治療標靶方面的應用不斷增加，生化試劑能夠實現精確、高效的基因組分析。這種能力支持開發針對個別基因圖譜的個人化療法，增加了對高品質試劑的需求，以確保基因組研究和臨床診斷的準確性和可靠性。

到2032年，細胞和組織培養領域將獲得前景看好的生化試劑市場佔有率。這些試劑在受控實驗室環境中維持細胞活力、生長和分化方面發揮著至關重要的作用。隨著在藥物開發、再生醫學和生物加工中的應用不斷增加，生化試劑促進了細胞和組織的培養和操作，以用於各種研究和治療目的。它們在確保基於細胞的測定和實驗的可重複性和可靠性方面的作用強調了它們在推進生物醫學科學和滿足生物製藥行業不斷變化的需求方面的重要性。

2024年至2032年期間，歐洲生化試劑市場將以令人印象深刻的複合年成長率成長。歐洲對生物製藥和個人化醫療研發的重視正在放大對先進生化試劑的需求。此外，確保高標準研究和診斷的嚴格監管框架正在為生化試劑行業的擴張創造有利的環境。慢性病盛行率的增加和人口老化也導致需求增加，因為生化試劑在疾病診斷、治療監測和治療開發中發揮關鍵作用。

產業生態系統分析
產業影響力
- 成長動力
  - 增加生命科學和生物技術領域的研發活動
  - 慢性病和傳染病的發生率上升
  - 生化研究的技術進步
- 產業陷阱與挑戰
  - 生化試劑成本高
  - 嚴格的監管政策和品質控制標準
成長潛力分析
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按產品類型，2021 - 2032

主要趨勢
聚合酶鍊式反應試劑盒
細胞和組織培養試劑
電泳試劑
色譜試劑
其他產品類型

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
藥物發現與開發
基因組學
蛋白質體學
診斷
生物技術研究
其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
生物技術和製藥公司
學術及研究機構
醫院和診斷實驗室
合約研究組織 (CRO) 和合約開發和製造組織 (CDMO)

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Abbott Laboratories
Agilent Technologies Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Merck KGaA
F. Hoffmann-La Roche Ltd.
Johnson and Johnson
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Waters Corporation

簡介目錄

Product Code: 9194

Global Biochemical Reagents Market will infer over 8.5% CAGR from 2024 to 2032, driven by the growing shift toward personalized medicine. As healthcare moves toward tailored treatments based on individual genetic profiles, there is a heightened demand for biochemical reagents used in genetic testing and molecular diagnostics. These reagents play a crucial role in identifying genetic variations and biomarkers that influence disease susceptibility and treatment response.

Against this backdrop, in July 2024, Wisconsins Biohealth Tech Hub secures USD 49 million in federal funding to advance precision medicine. The investment aims to boost innovation, production capabilities, and workforce development within the personalized medicine sector.

This trend reflects a broader emphasis on precision healthcare, where accurate and specific biochemical assays are essential for developing targeted therapies and improving patient outcomes, thriving the market forward in research, diagnostics, and therapeutic applications.

The overall biochemical reagents market is categorized based on product type, application, end-use, and region.

The genomics segment will exhibit a remarkable CAGR during 2024-2032. The genomics segment will experience an upsurge due to advancements in genomic research and personalized medicine. These reagents are essential in genomics for tasks such as DNA sequencing, PCR amplification, and gene expression analysis. With increasing applications in understanding genetic variations, disease mechanisms, and therapeutic targets, biochemical reagents enable precise and efficient genomic analysis. This capability supports the development of personalized therapies tailored to individual genetic profiles, augmenting the demand for high-quality reagents that ensure accuracy and reliability in genomic studies and clinical diagnostics.

The cell and tissue culture segment will garner a promising biochemical reagents market share by 2032. The demand for biochemical reagents is growing in the cell and tissue culture segment primarily due to advancements in biotechnology and pharmaceutical research. These reagents play a crucial role in maintaining cell viability, growth, and differentiation in controlled laboratory environments. With increasing applications in drug development, regenerative medicine, and bio-processing, biochemical reagents facilitate the cultivation and manipulation of cells and tissues for various research and therapeutic purposes. Their role in ensuring reproducibility and reliability in cell-based assays and experiments underscores their importance in advancing biomedical sciences and meeting the evolving needs of bio pharmaceutical industries.

Europe biochemical reagents market will grow at an impressive CAGR during the period from 2024 to 2032. The demand for biochemical reagents is experiencing growth in Europe, driven by robust investments in biotechnology and healthcare infrastructure. Europe focus on research and development in bio-pharmaceuticals and personalized medicine is amplifying the need for advanced biochemical reagents. Additionally, stringent regulatory frameworks that ensure high standards of research and diagnostics are fostering a favorable environment for biochemical reagents industry expansion. The increasing prevalence of chronic diseases and aging populations also contribute to heightened demand, as biochemical reagents play a critical role in disease diagnosis, treatment monitoring, and therapeutic development.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing R&D activities in life sciences and biotechnology
  - 3.2.1.2 Rising incidence of chronic and infectious diseases
  - 3.2.1.3 Technological advancements in biochemical research
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of biochemical reagents
  - 3.2.2.2 Stringent regulatory policies and quality control standards
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Polymerase chain reaction reagent kits
5.3 Cell and tissue culture reagents
5.4 Electrophoresis reagents
5.5 Chromatography reagents
5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 KEY trends
6.2 Drug discovery and development
6.3 Genomics
6.4 Proteomics
6.5 Diagnostics
6.6 Biotechnology research
6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Biotechnology & pharmaceutical companies
7.3 Academic and research institutes
7.4 Hospitals and diagnostic laboratories
7.5 Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs)

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa